Skip to main content
Premium Trial:

Request an Annual Quote

FDA Licenses Linguamatics' Text Mining Platform for Use in Drug Safety Studies

Premium

Linguamatics said this week that the US Food and Drug Administration has licensed its I2E text mining platform to support laboratory research efforts around drug safety.

Specifically, the FDA’s Center for Drug Evaluation and Research will use I2E to mine published literature and drug product labels for information about drug toxicity mechanisms, disease processes, and other biomedical topics.

Linguamatics’ I2E is a natural language processing-based program that enables users to identify, extract, synthesize, and analyze data and relationships between genes, diseases, compounds, and side effects.

Financial details of the agreement were not disclosed

The Scan

Study Points to Tuberculosis Protection by Gaucher Disease Mutation

A mutation linked to Gaucher disease in the Ashkenazi Jewish population appears to boost Mycobacterium tuberculosis resistance in a zebrafish model of the lysosomal storage condition, a new PNAS study finds.

SpliceVault Portal Provides Look at RNA Splicing Changes Linked to Genetic Variants

The portal, described in Nature Genetics, houses variant-related messenger RNA splicing insights drawn from RNA sequencing data in nearly 335,700 samples — a set known as the 300K-RNA resource.

Automated Sequencing Pipeline Appears to Allow Rapid SARS-CoV-2 Lineage Detection in Nevada Study

Researchers in the Journal of Molecular Diagnostics describe and assess a Clear Labs Dx automated workflow, sequencing, and bioinformatic analysis method for quickly identifying SARS-CoV-2 lineages.

UK Team Presents Genetic, Epigenetic Sequencing Method

Using enzymatic DNA preparation steps, researchers in Nature Biotechnology develop a strategy for sequencing DNA, along with 5-methylcytosine and 5-hydroxymethylcytosine, on existing sequencers.